mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |